Role of neutrophil dysfunction in the pathogenesis of systemic lupus erythematosus
- 作者: Smirnova E1, Krasnova T1, Proskurnina E1, Mukhin N1,2
-
隶属关系:
- ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»
- ФБГОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России
- 期: 卷 89, 编号 12 (2017)
- 页面: 110-113
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32371
- DOI: https://doi.org/10.17116/terarkh20178912110-113
- ID: 32371
如何引用文章
全文:
详细
Neutrophil dysfunction plays a considerable role.in systemic lupus erythematosus (SLE) The protective function of neutrophils is carried out through various mechanisms: isolation of granular antimicrobial peptides (gAMP), microbial phagocytosis with subsequent degradation via reactive oxygen species inside the phagolysosomes; as well as bactericidal action due to the release of networks from chromatin and gAMP, also called neutrophil extracellular traps (NECTs). The development of neutropenia in SLE has multiple causes, including the formation of antibodies directly to leukocytes; that of neutralizing autoantibodies to the growth factors of neutrophils and cells - myeloid precursors; bone marrow suppression; involvement of neutrophils in the processes of apoptosis and NETosis. Neutrophils in SLE are characterized by reduced phagocytic ability and pathological oxidative activity. In SLE, there is a decrease in the ability to remove the products of neutrophil apoptosis, which is correlated with disease activity. SLE patients are noted to have a higher expression level of the genes specific for low-density granulocytes, an abnormal immature neutrophil population. The impaired processes of formation of NECTs and removal NETosis products play a substantial role in the pathogenesis of SLE. It is shown that the abnormal formation of NECTs also causes endothelial injury and increases the risk of thromboses. The design of novel drugs that act on the specific parts of the formation of NECTs or contribute to their removal from the extracellular environment can propel therapy for SLE and other autoimmune diseases to new heights. There is evidence for further investigations of neutrophil-mediated pathogenetic processes in SLE in order to identify potential therapeutic targets and to understand the mechanisms of action of drugs used in clinical practice.
作者简介
E Smirnova
ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»Москва, Россия
T Krasnova
ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»Москва, Россия
E Proskurnina
ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»Москва, Россия
N Mukhin
ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова»; ФБГОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава РоссииМосква, Россия
参考
- Bennett L. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood. Journal of Experimental Medicine. 2003;15(5):711-723. https://doi.org/10.1084/jem.20021553
- Carmona-Rivera C. Low-Density Granulocytes: A Distinct Class of Neutrophils in Systemic Autoimmunity. Seminars in Immunopathology. 2013;35(4):455-463. https://doi.org/10.1007/s00281-013-0375-7
- Singh N, Traisak P, Martin K, Kaplan M, Cohen P, Denny M. Genomic Alterations in Abnormal Neutrophils Isolated from Adult Patients with Systemic Lupus Erythematosus. Arthritis research & therapy. 2014;16(4):R165. https://doi.org/10.1186/ar4681
- Garcia-Romo G. Netting Neutrophils Are Major Inducers of Type I Ifn Production in Pediatric Systemic Lupus Erythematosus. Science Translational Medicine. 2011;3(73):73ra20. https://doi.org/10.1126/scitranslmed.3001201
- Lande R. Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus. Science Transltional Medicine. 2011;3(73):73ra19. https://doi.org/10.1126/scitranslmed.3001180
- Hakkim A, Furnrohr B, Amann K, Laube B, Abed U, Brinkmann V, Herrmann M, Voll R, Zychlinsky A. Impairment of Neutrophil Extracellular Trap Degradation Is Associated with Lupus Nephritis. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(21):9813-9818. https://doi.org/10.1073/pnas.0909927107
- Kahlenberg J, Carmona-Rivera C, Smith C, Kaplan M. Neutrophil Extracellular Trap-Associated Protein Activation of the Nlrp3 Inflammasome Is Enhanced in Lupus Macrophages. Journal of immunology. 2013;190(3):1217-1226. https://doi.org/10.4049/jimmunol.1202388
- Zhang S, Lu X, Shu X, Tian X, Yang W, Zhang Y, Wang G. Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus. Internal Medicine 2014;53(24):2763-2771. https://doi.org/10.2169/internalmedicine.53.2570
- Pieterse E, Hofstra J, Berden J, Herrmann M, Dieker J, van der Vlag J. Acetylated Histones Contribute to the Immunostimulatory Potential of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus. Clinical and experimental immunology. 2015; 179(1):68-74. https://doi.org/10.1111/cei.12359
- van Bavel C, Dieker J, Muller S, Briand J, Monestier M, Berden J, van der Vlag J. Apoptosis-Associated Acetylation on Histone H2b Is an Epitope for Lupus Autoantibodies. Molecular immunology. 2009;47(2-3):511-516. https://doi.org/10.1016/j.molimm.2009.08.009
- Li P, Li M, Lindberg MR, Kenneth MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. The Journal of Experimental Medicine. 2010;207 (9):1853-1862. https://doi.org/10.1084/jem.20100239
- Sang A, Zheng Y, Morel L. Contributions of B Cells to Lupus Pathogenesis. Molecular immunology. 2014;62(2):329-338. https://doi.org/10.1016/j.molimm.2013.11.013
- Coquery C, Wade N, Loo W, Kinchen J, Cox K, Jiang C, Tung K, Erickson L. Neutrophils Contribute to Excess Serum Baff Levels and Promote Cd4+ T Cell and B Cell Responses in Lupus-Prone Mice. PloS one. 2014;9(7):e102284. https://doi.org/10.1371/journal.pone.0102284
- Mak A, Kow N. Imbalance between Endothelial Damage and Repair: A Gateway to Cardiovascular Disease in Systemic Lupus Erythematosus. BioMed research international. 2014;(2014):178721. https://doi.org/10.1155/2014/178721